Skip to content

The efficacy of medical versus surgical abortion for first trimester therapeutic in Iran; A quasi experimental analysis

The efficacy of medical versus surgical abortion for first trimester therapeutic in Iran; A quasi experimental analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210916052504N1
Enrollment
140
Registered
2021-11-20
Start date
2022-02-20
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Missed abortion. Condition 2: Complications following (induced) termination of pregnancy. Condition 3: (Induced) termination of pregnancy with other and unspecified complications. Missed abortion Complications following (induced) termination of pregnancy (Induced) termination of pregnancy with other and unspecified complications

Interventions

Intervention 1: Medical intervention with three doses of misoprostol 400 mg (with trade name Cytotec) sublingual and vaginal 6 hours apart. Intervention 2: Dilation and curettage (D & C), the dilation

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women seeking first trimester therapeutic abortion

Exclusion criteria

Exclusion criteria: Illegal abortions Underlying disease (including neoplasms)

Design outcomes

Primary

MeasureTime frame
Success rate of abortion treatment in the first trimester of pregnancy termonation. Timepoint: The patient's clinical condition based on the physician's opinion 14 days after receiving the first medication or surgery. Method of measurement: Questionnaire, test, imaging and doctor's opinion.

Secondary

MeasureTime frame
Possible side effects of treatment include severe bleeding, need to repeat the abortion process, infection or damage to the uterus. Timepoint: Clinical status of the patient 14 days after receiving the first treatment intervention. Method of measurement: Questionnaire, test, imaging and doctor's opinion.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Husseini Barghazan

Iran University of Medical Sciences

Hoseyni.sa@iums.ac.ir+98 21 8867 1615

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026